Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Cages were changed weekly
However, as more people started using GLP-1 drugs like semaglutide and tirzepatide, some reported unexpected changes in behavior, including: Less interest in alcohol Reduced urge to smoke Lower drive for compulsive snacking or reward-based eating By themselves, patient stories do not prove that GLP-1 medications treat addiction
Body composition (DEXA or similar) only useful with a long enough window to detect change
"Oral SLU-PP-332" marketed with claims of "high oral bioavailability" that contradicts Billon 2025 (PMID 41421047), which is the paper that explicitly identified the parent compound's lack of oral bioavailability as the reason SLU-PP-915 was developed
& Nateghi, H
